Moroccan pharmaceutical tycoon Lamia Tazi loses $9.4 million from her stake in Sothema
Tazi owns a sizable 3.93-percent stake in the company, totaling 282,644 shares.
Skip to content
Tazi owns a sizable 3.93-percent stake in the company, totaling 282,644 shares.
The market value of Douiri’s 6.88-percent interest in Mutandis is assessed at $15.36 million.
Lazraq is one of Morocco’s wealthiest businesspeople.
Sothema produces over 60 million units of pharmaceuticals yearly.
At the end of 2021, Disway, Morocco’s first technology distributor, recorded a revenue of about $190 million.
His foundation has donated provisions to a polyclinic in Nima in Greater Accra.
The plant will facilitate fertilizer production using gas reserves, improve Nigerian agriculture and enhance bilateral trade between the countries.
U.S. billionaire Mark Cuban is making moves to invest in Morocco’s emerging fintech sector.